Free Trial
NASDAQ:GNOM

Global X Genomics & Biotechnology ETF (GNOM) Price, Holdings, & News

$8.71 0.00 (0.00%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$8.36 -0.36 (-4.08%)
As of 08/8/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

Key Stats

Today's Range
$8.67
$8.80
50-Day Range
$7.92
$9.08
52-Week Range
$6.80
$11.68
Volume
53,406 shs
Average Volume
64,676 shs
Market Capitalization
$43.72 million
Assets Under Management
$43.74 million
Dividend Yield
N/A
Net Expense Ratio
0.50%
Aggregate Rating
Moderate Buy

ETF Overview

Global X Genomics & Biotechnology ETF Expenses

TypeGNOMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.57%0.56%0.54%0.53%
Other Expenses0.00%0.57%0.56%0.52%0.56%
Total Expense0.50%0.74%0.76%0.73%0.73%
Fee Waiver0.00%-0.76%-0.66%-0.50%-0.63%
Net Expense0.50%0.60%0.63%0.63%0.60%
Receive GNOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

GNOM ETF News Headlines

10x Genomics Misses Revenue Forecast
One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
Global X Genomics & Biotechnology UCITS ETF (GNOM.L)
GNOM Global X Genomics & Biotechnology ETF
See More Headlines

GNOM ETF - Frequently Asked Questions

Global X Genomics & Biotechnology ETF's stock was trading at $9.71 at the beginning of the year. Since then, GNOM shares have decreased by 10.3% and is now trading at $8.71.

Top institutional shareholders of Global X Genomics & Biotechnology ETF include Oppenheimer Asset Management Inc. (1.79%), Insight Advisors LLC PA (1.19%), Stratos Wealth Partners LTD. (1.15%) and Sightline Wealth Advisors LLC (0.99%).

Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Global X Genomics & Biotechnology ETF investors own include Meta Platforms (META), NVIDIA (NVDA), Teladoc Health (TDOC), Intel (INTC), Alibaba Group (BABA) and PayPal (PYPL).

Fund Details

Issuer
Global X
Fund Name
Global X Genomics & Biotechnology ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:GNOM
Inception Date
4/5/2019
Fund Manager
Chang Kim, James Ong, Nam To, Wayne Xie

Fund Focus

Asset Class
Equity
Benchmark
Solactive Genomics Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
50

Fund Statistics

Assets Under Management
$43.73 million
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
Global X Management Company LLC
Advisor
Global X Management Company LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
SEI Investments Distribution Co.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
Susquehanna

Options

Optionable
Optionable
Options Volume
1
Put Options
2
Call Options
1
Short Interest
16,600 shs

Miscellaneous

Beta
1.03
Creation Unit
50,000
Creation Fee
$500.00
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Top 10 GNOM Holdings

GNOM Sector Exposure

GNOM Industry Exposure


This page (NASDAQ:GNOM) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners